Acepodia

Acepodia is a legitimate clinical-stage biotechnology company (Taipei Exchange: 6976) with a market capitalization of ~$319M USD. The project utilizes Nobel Prize-winning click chemistry (ACC platform) for cancer cell therapy, indicating high technical innovation and real-world utility. However, the specific submission provided contains significant inaccuracies (claiming 'most people' have used the product, listing 'energy-solutions' as technology), which severely penalized the Response Quality and Traction Quality scores. Despite the poor submission data, the entity's verifiable clinical progress (FDA IND clearances) and valuation sustain a high Proof of Usefulness score.